Clinical efficacy of Niaoduqing Granule combined with Febusta in treatment of hyperuricemia with renal damage
LI Juan
YANG Lin
Abstract：Objective To investigate the clinical efficacy of Niaoduqing Granule combined with Febusta in the treatment of renal damage in patients with hyperuricemia(HUA).Methods Eighty-two HUA patients with renal damage in our hospital from March 2020 to March 2022 were divided into observation group(n = 41)and control group(n = 41).The control group was treated with Febusta,while observation group with Niaoduqing gran-ule and Febusta.Two groups were treated for 12 weeks.Blood uric acid,renal function,Cys C and β2-MG level change and adverse reactions in the two groups were compared.Results The total effective rate in the observation group was higher than in the control group(P<0.05).After treatment,the level of serum uric acid,BUN,Scr,24h Upro,Cys C and β2-MG decreased in the two groups(P<0.05),with more significant results in the observa-tion group(P<0.05).No obvious adverse reactions were observed in the two groups.Conclusion Niaoduqing Granule combined with Febusta has good effect in treating HUA patients with renal impairment.It reduces the level of blood uric acid,Cys C and β2-MG,which protect the renal function of patients,
Keywords：Niaoduqing GranuleFebusta tablethyperuricemiarenal damage
Publication Date：2024-05-25
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 1418-1422 )